Orient Securities, a shareholder of Jiaying Pharmaceutical (002198.SZ), plans to reduce its holdings by no more than 1%

Zhitongcaijing · 10/16 12:25

According to Zhitong Finance App, Jiaying Pharmaceutical (002198.SZ) announced that Oriental Securities, the shareholder of the company, currently holds 57.223 million shares of the company (accounting for 11.28% of the company's total share capital) and plans to reduce its holdings of 5.0751 million shares (no more than 1% of the company's total share capital ratio) through centralized bidding transactions within three months after the announcement of the current holdings reduction plan.